| Offering Information |
| Expected Date | WITHDRAWN |
| Proposed Exchange/Ticker |
Nasdaq: MBI |
| Security Type |
Common Stock |
| Lead Underwriter |
Rodman & Renshaw Inc Dundee Securities Corporation ThinkEquity Partners |
| Days In Registration |
808 |
| Date Filed |
16-Nov-2009 |
| Form Filed | F-1 |
Fundamentals
(Year Ending December 2011) |
| Industry |
Healthcare |
| Business Description |
Med BioGene Inc, located in Vancouver, British Columbia, is a biotechnology company engaged in the development and commercialization of clinical laboratory diagnostic and screening tests. The company was founded in 2002. |
| Revenue |
- |
| Net Income |
-$2M |
| Shares Outstanding (post-offering) |
4.24M |
| Contact |
- |
| Number of Employees |
11 |
|
| Original Filing Information |
| US |
| Shares Filed |
- |
| Secondary Shares Filed | - |
| · As a Percent |
- |
| Primary Shares Filed |
- |
| · As a Percent |
- |
| Overallotment Shares Filed |
- |
| File Amount |
- |
| File Price Range |
- - - |
| File Mid Price |
- |
|
